Board Approved Scheme Of Amalgamation Of Unit With Co
03/02/2020 11:04
Feb 3 (Reuters) - Dr. Lal PathLabs Ltd DLPA.NS :
* DR. LAL PATHLABS LTD -BOARD APPROVED SCHEME OF
AMALGAMATION
BETWEEN APL INSTITUTE OF CLINICAL LABORATORY & RESEARCH, A UNIT
WITH CO
Source text for Eikon: ID:
Further company coverage: DLPA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Lal PathLabs
See all newsBrief: Lal Pathlabs Says Unit Acquired Remaining 30% Equity Stake In Centrapath Labs Private Limited
India's Dr Lal PathLabs rises as Axis Securities initiates with 'buy'
India's Dr Lal PathLabs rises; analysts back SN Genelab deal
Brief: Lal Pathlabs Says Subsidiary Incorporated Dr Lal Pathlabs Indomed In Tashkent, Uzbekistan
India's Dr Lal PathLabs jumps to 4-year high after quarterly profit rise